Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-14

Clinical Trial Update: Characteristics of Cord Blood Immunologic Parameters of Infants <32 Weeks Gestation

View source ↗

Summary

A terminated clinical trial studied cord blood immunologic parameters in infants born before 32 weeks gestation. Results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Premature Birth, Sepsis | Status: TERMINATED | Results posted: 2015-12-14